Gilead’s Competition: Other Stocks To Watch In Immunotherapy – Seeking Alpha
Seeking Alpha |
Gilead's Competition: Other Stocks To Watch In Immunotherapy
Seeking Alpha Novartis has immunotherapy cancer treatments that are ahead of Gilead/Kite in terms of approvals. While it certainly won't stop Gilead from getting into the market, this represents a clear price competitor (good for consumers, bad for earnings … |
